Search - tctmd.com

Displaying 21 - 40 of 205

Sort: Relevancy | Date

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

L.A. McKeown

February 25, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

Presenter: Run-Lin Gao

September 25, 2019

Presentation TCT 2019

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Presenter: Jens Wiebe

September 25, 2019

Presentation TCT 2019

TCT 42: Polymer-free Drug-coated vs. Bare-metal Coronary Stents in Patients Undergoing Non-cardiac Surgery A Subgroup Analysis of the LEADERS FREE Trial

Presenter: Abdelhakim Allali

September 25, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

News Opinion Off Script TCT 2018

Off Script: Phantom Hearts and the Elusive Nature of Angina

Kwan S. Lee

October 11, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

Presentation TCT 2018

PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction

Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller

September 23, 2018

Presentation TCT 2018

RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease

Presenter: Fernando Alfonso, Juan F. Granada, Runlin Gao

September 23, 2018

Presentation TCT 2018

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

Presenter: Fernando Alfonso, Juan F. Granada, YunDai Chen

September 23, 2018

Advertisement

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

TCT 42: Polymer-free Drug-coated vs. Bare-metal Coronary Stents in Patients Undergoing Non-cardiac Surgery A Subgroup Analysis of the LEADERS FREE Trial

TCTMD’s Top 10 Most Popular Stories for August 2019

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

TCTMD’s Top 10 Most Popular Stories for February 2019

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Off Script: Phantom Hearts and the Elusive Nature of Angina

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction

RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content